Tag: Nitroprusside

Acute aortic dissection is a life-threatening emergency with a mortality rate that can increase by 1-2% per hour if left untreated. A critical component of the initial stabilization is determining **what vasopressors are used for aortic dissection** and controlling hemodynamics to reduce stress on the weakened aortic wall. This medical management is crucial for improving patient outcomes and buying time for definitive surgical or endovascular treatment.

Originally approved by the FDA in 1974, sodium nitroprusside is a potent and fast-acting vasodilator used intravenously in critical care settings. So, what is nitroprusside used for, and why does its use require such intensive monitoring? This article explores its primary clinical applications, mechanism of action, and associated risks.